Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
about
Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients.Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat.A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.Role of the Helicobacter hepaticus flagellar sigma factor FliA in gene regulation and murine colonizationHelicobacter pylori uses motility for initial colonization and to attain robust infectionImmunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins.
P2860
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1989
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
@en
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
@nl
type
label
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
@en
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
@nl
prefLabel
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
@en
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
@nl
P2093
P2860
P921
P1476
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis
@en
P2093
P2860
P304
P407
P577
1989-12-01T00:00:00Z